<h1>Rehab center faces scrutiny over clinical claims, outcome rates, licensing, consent, and HIPAA and FTC Section 5 compliance</h1> A rehabilitation provider issued a press release claiming integrated, evidence-based alcohol and mental-health treatment-including medically supervised withdrawal, dual-diagnosis therapy, tailored psychotherapy, holistic supports, 90- and 180-day programs, long-term follow-up, and facility-based care-asserting a 65% six-month sobriety rate for three-month program completers. The distributor disclaimed editorial responsibility. Legal issues include potential regulatory and advertising scrutiny over substantiation of clinical and outcome claims, licensing and scope-of-practice compliance for medical/psychiatric services, duty to obtain informed consent and protect health data, and exposure to consumer-protection or professional-liability claims if representations are misleading or unsupported.